Hormone Therapy Prescribing Patterns in the United States

@article{Buist2004HormoneTP,
  title={Hormone Therapy Prescribing Patterns in the United States},
  author={D. Buist and K. Newton and D. Miglioretti and Kevin Beverly and M. Connelly and S. Andrade and C. Hartsfield and F. Wei and K. Chan and L. Kessler},
  journal={Obstetrics \& Gynecology},
  year={2004},
  volume={104},
  pages={1042-1050}
}
OBJECTIVE: We sought to examine prescribing patterns (prevalence and rates of initiation and discontinuation) for estrogen plus progestin (hormone therapy [HT] and estrogen alone [ET]) in the United States in the 2 years before the published results of Women's Health Initiative's (WHI) HT trial's early termination and for 5 months after their release. METHODS: We conducted an observational cohort study of 169,586 women aged 40–80 years who were enrolled in 5 health maintenance organizations in… Expand
The impact of comorbidities on hormone use
The impact of comorbidities on hormone use. After the 2000 release of the Women's Health Initiative.
Hormone therapy discontinuation: physician practices after the Women's Health Initiative
Hormone therapy initiation after the Women's Health Initiative
Factors associated with successful discontinuation of hormone therapy.
Discontinuation of hormone therapy in the French GAZEL cohort 1990-2006.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 41 REFERENCES
Postmenopausal hormone replacement therapy: scientific review.
Use of Hormone Replacement Therapy by Postmenopausal Women in the United States
Failure of estrogen plus progestin therapy for prevention.
Predictors of Difficulty When Discontinuing Postmenopausal Hormone Therapy
...
1
2
3
4
5
...